Antibody-drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis.

Ther Adv Med Oncol · 2024 · PMC11580099 · PMID 39574495

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significancep = 0.24not close (p > 0.1)

Objective responses were numerically higher in the HoR-positive compared to the HoR-negative group (48% vs 38%), yet it did not reach statistical significance ( p = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.